NewsCONTROVERSY OF THE YEAR

Biomedical Ethics on the Front Burner

Science  22 Dec 2000:
Vol. 290, Issue 5500, pp. 2225
DOI: 10.1126/science.290.5500.2225

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

It was a hot year for debates over research ethics. Controversy erupted in late 1999 after the death of 18-year-old Jesse Gelsinger in a gene-therapy clinical trial at the University of Pennsylvania. Because Penn and one of its clinicians had a financial stake in a gene-therapy company, questions about potential conflicts of interest arose at once.

Related Content